Latest News about CMPS
Recent news which mentions CMPS
Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
November 11, 2021
From Motley Fool
75 Biggest Movers From Yesterday
November 10, 2021
From Benzinga
COMPASS Pathways plc (CMPS) Q3 2021 Earnings Call Transcript
November 09, 2021
Tickers
CMPS
From Motley Fool
Why Compass Pathways Shares Are Slumping More Than 22% Tuesday
November 09, 2021
Tickers
CMPS
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 09, 2021
From Benzinga
58 Stocks Moving In Monday's Mid-Day Session
November 09, 2021
From Benzinga
EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release
November 09, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
From Benzinga
This Psychedelics Unicorn's Stock Is Up 50% In One Month—Beating Bitcoin, Ethereum And Dogecoin
November 04, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
October 29, 2021
From Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
From Benzinga
These 4 Psychedelic Biotech Stocks Are Leading the Pack
October 26, 2021
From Motley Fool
Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race
October 20, 2021
From Benzinga
Psychedelic Unicorn Compass Pathways Receives New Patent Approval
October 20, 2021
Tickers
CMPS
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
This Company Just Extended its Reach into the United Kingdom by Opening its First Ketamine Therapy Clinic
October 18, 2021
From Benzinga
From Benzinga
From MarketWatch
3 Biotech Stocks With Huge Catalysts This Fall
September 29, 2021
From Motley Fool
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
From Benzinga
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
September 20, 2021
From Benzinga
Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0
September 15, 2021
From Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 08, 2021
From Benzinga
3 Biotech Stocks Wall Street Expects to Double Soon
September 07, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.